1. Remembering Dr Jerry Labadie 1957–2012

   • I. Ralph Edwards

   In Memory 13 December 2012 Pages: 783 - 784

2. Safety Monitoring of Herb-Drug Interactions

   • Souad Skalli
   • Rachida Soulaymani Bencheikh

   Current Opinion 13 December 2012 Pages: 785 - 791

   

3. Pregabalin Treatment for Peripheral Neuropathic Pain

   • Setsuro Ogawa
   • Jo Satoh
   • Makoto Suzuki

   Review Article 13 December 2012 Pages: 793 - 806

   

4. Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting

   • Jackie Inch
   • Margaret C. Watson
   • Yellow Card Study Collaboration

   Systematic Review 13 December 2012 Pages: 807 - 818

   

5. Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders

   • Hoda Moteshafi
   • Simon Zhornitsky
   • Emmanuel Stip

   Systematic Review 13 December 2012 Pages: 819 - 836

   

6. Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance Centre

   • Betsabé Sánchez-Sánchez
   • Marina Altagracia-Martínez
   • Juan Manuel Martínez-Núñez

   Short Communication 13 December 2012 Pages: 837 - 844

   

7. First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines

   • Geneviéve Durrieu
   • Aurore Palmaro
   • French Network of Pharmacovigilance Centres

   Original Research Article 13 December 2012 Pages: 845 - 854

   

8. Effect of Competition Bias in Safety Signal Generation

   • Antoine Pariente
   • Paul Avillach
   • Association Française des Centres Régionaux de Pharmacovigilance (CRPV)

   Original Research Article 13 December 2012 Pages: 855 - 864

   

9. Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations

   • Xiwu Lin
   • Daniel Parks
   • Kwan Lee

   Original Research Article 13 December 2012 Pages: 865 - 875

   

10. Abstracts

    Abstract 13 December 2012 Pages: 877 - 970